Physician Resources

Multipart collaboration brings data-driven care management tools to patients


 

One Drop announced on Oct. 31 a multipart collaboration with Fitbit to bring enhanced data-driven care management tools to the diabetes community.

One Drop users will now be able to sync Fitbit intraday data to their One Drop accounts. The first initiative will be to help users better understand the impact of physical activity on blood glucose management. The app software also will analyze user-generated health data points with the goal of gaining deeper insights and improving health outcomes for all people with diabetes worldwide. It can potentially allow users to see how their physical activity impacts blood glucose levels. Users can review these data with their very own Certified Diabetes Educator as they work together to meet personalized health goals.

In a study published in JMIR Diabetes in August 2017, results showed a 1.1%-1.3% absolute reduction in hemoglobin A1C in just 4 months in patients using One Drop. It is noted that this was a more significant reduction than other published research suggested was possible using a mobile care management app.

“By integrating Fitbit data and creating an app for Fitbit Ionic, we will be able to provide our users and their health care providers with more data and deeper insights to better manage their diabetes,” said Jeff Dachis, CEO and founder of One Drop, in a press release.

Read the full press release here.

Recommended Reading

Exercise reduces T1DM mortality risk
MDedge Endocrinology
Oral semaglutide achieves outcomes similar to those of subcutaneous semaglutide
MDedge Endocrinology
Vitality predicts T2DM major cardiovascular event risk
MDedge Endocrinology
SGLT inhibition back on track in phase 3 type T1DM trial
MDedge Endocrinology
FDA panel advises approval of semaglutide to lower HbA1c in patients with type 2 diabetes
MDedge Endocrinology
Care needed using sotagliflozin as add-on to insulin in T1DM
MDedge Endocrinology
Autoimmune endocrinopathies spike after celiac disease diagnosis
MDedge Endocrinology
DiaRem score predicts remission of type 2 diabetes after sleeve gastrectomy
MDedge Endocrinology
Better trials, more cooperation needed to improve continuous glucose monitoring devices
MDedge Endocrinology
One-step GDM diagnosis: Research moves closer
MDedge Endocrinology